| Literature DB >> 32022507 |
Jie Chen1,2, Weicong Cai1,3, Liping Li1.
Abstract
OBJECTIVE: To evaluate usage of renal artery embolization (RAE) for renal injuries and discuss the indications for this treatment.Entities:
Keywords: Disease Management; Embolization, Therapeutic; Renal Artery
Mesh:
Year: 2020 PMID: 32022507 PMCID: PMC7025829 DOI: 10.1590/S1677-5538.IBJU.2019.0506
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
AAST renal injury grading scale (11).
| Grade* | Description of injury |
|---|---|
| 1 | Contusion or nonexpanding subcapsular hematoma No laceration |
| 2 | Nonexpanding perirenal hematoma Cortical laceration < 1 cm deep without extravasation |
| 3 | Cortical laceration > 1 cm without urinary extravasation |
| 4 | Laceration: through corticomedullary junction into collecting system or Vascular: segmental renal artery or vein injury with contained hematoma, or partial vessel laceration, or vessel thrombosis |
| 5 | Laceration: shattered kidney or Vascular: renal pedicle or avulsion |
*Advance one grade for bilateral injuries up to grade III.
Figure1Renal trauma staging.
Basic information of the renal trauma patients admitted to hospitals A and B during 2006-2015.
| Hospital A (N=264) | Hospital B (N=304) | p | |
|---|---|---|---|
| Male(%) | 200 (75.8) | 234(77) | 0.733 |
| Age, mean(SD), year | 33.59(17.13) | 32.63(16.69) | 0.499 |
| Hematuria | 207(78.4) | 220(72.4) | 0.096 |
| I-III | 252(95.5) | 270(88.8) | |
| IV-V | 12(4.5) | 34(11.2) | |
| LOS, median (IQR), day | 20.5(14.00,34.00) | 16.0(9.00,30.00) | <0.001 |
| Cost, median (IQR), RMB | 16483.7(7888.72,43857.72) | 15950.9(8408.51,33042.57) | 0.189 |
| Associated lesions, (%) | 159(60.2) | 253(83.2) | <0.001 |
| Blunt | 233(88.3) | 263(86.5) | |
| Penetrating | 31(11.7) | 41(13.5) | |
Comparison of the operative rates of patients with renal injury between 2006-2011 and 2012-2015 at hospital A.
| 2006-2011 N=133, n(%) | 2012-2015 N=131, n(%) | |||
|---|---|---|---|---|
| Treatment | 0.683 | 0.22 | ||
| Non-RROM* | 131 (98.5) | 128 (97.7) | ||
| RROM | 2(1.5) | 3(2.3) |
*including RAE and NOM.
Figure 2Comparison of the nonoperative rates for LGRT at hospitals A and B between 2006-2011 and 2012-2015.The conservative treatment rates of hospital A decreased from 98.41% to 92.86% ,with significantly different between two periods (p=0.008,χ2=9.761). The conservative treatment rates of hospital B were not significantly different between two periods (p=0.557, χ2=0.345).
Univariate and Multivariate Logistic Regression Model for Predicting RAE.
| Characteristics | Univariate OR(95% CI) | Multivariate OR(95% CI) | ||
|---|---|---|---|---|
| Age, y | 0.98(0.94-1.02) | 0.34 | - | - |
| LOS, mean, d | 1.00(1.00-1.01) | 0.51 | - | - |
| Sex | 2.63(0.32-21.40) | 0.37 | - | - |
| Hematuria (yes/no) | 2.25(0.28-18.38) | 0.45 | - | - |
| Cost | 1.00(1.00-1.00) | 0.23 | - | - |
| Associated lesions (yes/no) | 0.52(0.14-1.97) | 0.33 | - | - |
| - | - | |||
| Blunt | 1.00(ref.) | - | - | |
| Penetrating | 0.94(0.11-7.76) | 0.95 | - | - |
| Shock (yes/no) | 0.54(0.06-4.59) | 0.57 | - | - |
| Tachycardia (yes/no) | 2.00(0.52-7.64) | 0.31 | - | - |
| AAST renal grade | ||||
| LGRT | 1.00(ref.) | 1 (ref.) | ||
| HGRT | 13.677(2.94-13.58) | 0.001 | 13.56(2.91-63.06) | 0.578~2.215 |